Jia Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jia Li has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Felix von Stetten
Hahn-Schickard, Georges-Koehler-Allee 103, 79110 Freiburg, Germany
2 shared publications Anja Gerhardts
Hohenstein Institut für Textilinnovation gGmbH, Germany
1 shared publicationAnna M. Sobieraj
Institute of Food, Nutrition and Health, ETH Zurich, 8092 Zurich, Switzerland
1 shared publicationAnnerose Serr
University Medical Center Freiburg, Institute for Microbiology and Hygiene, 79104 Freiburg, Germany
1 shared publicationDominik Drossart
Institut für Lasertechnologien in der Medizin und Meßtechnik, University of Ulm, 89081 Ulm, Germany
1 shared publicationFlorian Hausladen
Institut für Lasertechnologien in der Medizin und Meßtechnik, University of Ulm, 89081 Ulm, Germany
1 shared publication
Latest Publications
- Open Access
- 22 June 2020
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (14) , 2549-2561
Point-of-care testing system for digital single cell detection of MRSA directly from nasal swabs
We present an automated point-of-care testing (POCT) system for rapid detection of species- and resistance markers in methicillin-resistant Staphylococcus aureus (MRSA) at the level of single cells, directly from nasal swab samples. Our novel system allows clear differentiation between MRSA, methicillin-sensitive S. aureus (MSSA) and methicillin-resistant coagulase-negative staphylococci (MR-CoNS), which is not the case for currently used real-time quantitative PCR based systems. On top, the novel approach outcompetes the culture-based methods in terms of its short time-to-result (1 h vs. up to 60 h) and reduces manual labor. The walk-away test is fully automated on the centrifugal microfluidic LabDisk platform. The LabDisk cartridge comprises the unit operations swab-uptake, reagent pre-storage, distribution of the sample into 20 000 droplets, specific enzymatic lysis of Staphylococcus spp. and recombinase polymerase amplification (RPA) of species (vicK) – and resistance (mecA) -markers. LabDisk actuation, incubation and multi-channel fluorescence detection is demonstrated with a clinical isolate and spiked nasal swab samples down to a limit of detection (LOD) of 3 ± 0.3 CFU μl−1 for MRSA. The novel approach of the digital single cell detection is suggested to improve hospital admission screening, timely decision making, and goal-oriented antibiotic therapy. The implementation of a higher degree of multiplexing is required to translate the results into clinical practice.
- 22 June 2020
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 20 (14) , 2549-2561
Open AccessPoint-of-care testing system for digital single cell detection of MRSA directly from nasal swabs
We present an automated point-of-care testing (POCT) system for rapid detection of species- and resistance markers in methicillin-resistant Staphylococcus aureus (MRSA) at the level of single cells, directly from nasal swab samples. Our novel system allows clear differentiation between MRSA, methicillin-sensitive S. aureus (MSSA) and methicillin-resistant coagulase-negative staphylococci (MR-CoNS), which is not the case for currently used real-time quantitative PCR based systems. On top, the novel approach outcompetes the culture-based methods in terms of its short time-to-result (1 h vs. up to 60 h) and reduces manual labor. The walk-away test is fully automated on the centrifugal microfluidic LabDisk platform. The LabDisk cartridge comprises the unit operations swab-uptake, reagent pre-storage, distribution of the sample into 20 000 droplets, specific enzymatic lysis of Staphylococcus spp. and recombinase polymerase amplification (RPA) of species (vicK) – and resistance (mecA) -markers. LabDisk actuation, incubation and multi-channel fluorescence detection is demonstrated with a clinical isolate and spiked nasal swab samples down to a limit of detection (LOD) of 3 ± 0.3 CFU μl−1 for MRSA. The novel approach of the digital single cell detection is suggested to improve hospital admission screening, timely decision making, and goal-oriented antibiotic therapy. The implementation of a higher degree of multiplexing is required to translate the results into clinical practice.
- Open Access
- 14 November 2018
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (1) , 31-67
Review: a comprehensive summary of a decade development of the recombinase polymerase amplification
RPA is a versatile complement or replacement of PCR, and now is stepping into practice.
- 14 November 2018
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (1) , 31-67
Open AccessReview: a comprehensive summary of a decade development of the recombinase polymerase amplification
RPA is a versatile complement or replacement of PCR, and now is stepping into practice.